Search research articles
Contact Us
Filters
Showing results (171-180 of 316) with videos related to
Page
of 32
Sort By:
Neurology
|
July 8, 2011
GBA-associated PD presents with nonmotor characteristics
K Brockmann, K Srulijes, A K Hauser, et al.
Acta Neurologica Scandinavica
|
June 1, 1997
CADASIL: skin biopsy allows diagnosis in early stages
M Ebke, M Dichgans, M Bergmann, et al.
Digestion
|
January 1, 1987
Reduction of gastric acidity with ranitidine or famotidine: early evening dosage is more effective than late evening dosage
P Bauerfeind, T Cilluffo, C Emde, et al.
Advances in Enzyme Regulation
|
January 1, 1985
Uridylate-trapping sugar analogs in combination with inhibitors of uridylate synthesis de novo and 5-fluorouridine
D Keppler, J Fauler, T Gasser, et al.
The Journal of Pathology
|
March 4, 2000
Allelic loss at the D9S171 locus on chromosome 9p13 is associated with progression of papillary renal cell carcinoma
P Schraml, D Müller, R Bednar, et al.
Journal of Neurochemistry
|
October 3, 2002
Glial cell line-derived neurotrophic factor up-regulates GTP-cyclohydrolase I activity and tetrahydrobiopterin levels in primary dopaminergic neurones
M Bauer, S Suppmann, M Meyer, et al.
Journal of Neurology
|
March 14, 2008
Polymorphisms in the proteasomal subunit alpha4 are not associated with Parkinson's disease
C B Lücking, P Lichtner, M Dichgans, et al.
Pediatric Research
|
July 1, 1990
Pubertal growth in chronic renal failure
F Schaefer, C Seidel, A Binding, et al.
Archives of Neurology
|
February 19, 2000
Striatal dopamine transporter binding assessed by [I-123]IPT and single photon emission computed tomography in patients with early Parkinson's disease: implications for a preclinical diagnosis
J Schwarz, R Linke, M Kerner, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
February 6, 1998
123I-IBZM binding compared with long-term clinical follow up in patients with de novo parkinsonism
J Schwarz, K Tatsch, T Gasser, et al.
Page
of 32
Search research articles
Search
Showing results (171-180 of 316) with videos related to
Sort By:
Page
of 32
Neurology
|
July 8, 2011
GBA-associated PD presents with nonmotor characteristics
K Brockmann, K Srulijes, A K Hauser, et al.
Acta Neurologica Scandinavica
|
June 1, 1997
CADASIL: skin biopsy allows diagnosis in early stages
M Ebke, M Dichgans, M Bergmann, et al.
Digestion
|
January 1, 1987
Reduction of gastric acidity with ranitidine or famotidine: early evening dosage is more effective than late evening dosage
P Bauerfeind, T Cilluffo, C Emde, et al.
Advances in Enzyme Regulation
|
January 1, 1985
Uridylate-trapping sugar analogs in combination with inhibitors of uridylate synthesis de novo and 5-fluorouridine
D Keppler, J Fauler, T Gasser, et al.
The Journal of Pathology
|
March 4, 2000
Allelic loss at the D9S171 locus on chromosome 9p13 is associated with progression of papillary renal cell carcinoma
P Schraml, D Müller, R Bednar, et al.
Journal of Neurochemistry
|
October 3, 2002
Glial cell line-derived neurotrophic factor up-regulates GTP-cyclohydrolase I activity and tetrahydrobiopterin levels in primary dopaminergic neurones
M Bauer, S Suppmann, M Meyer, et al.
Journal of Neurology
|
March 14, 2008
Polymorphisms in the proteasomal subunit alpha4 are not associated with Parkinson's disease
C B Lücking, P Lichtner, M Dichgans, et al.
Pediatric Research
|
July 1, 1990
Pubertal growth in chronic renal failure
F Schaefer, C Seidel, A Binding, et al.
Archives of Neurology
|
February 19, 2000
Striatal dopamine transporter binding assessed by [I-123]IPT and single photon emission computed tomography in patients with early Parkinson's disease: implications for a preclinical diagnosis
J Schwarz, R Linke, M Kerner, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
February 6, 1998
123I-IBZM binding compared with long-term clinical follow up in patients with de novo parkinsonism
J Schwarz, K Tatsch, T Gasser, et al.
Page
of 32